Tryfonia Mainou-Fowler

Tryfonia Mainou-Fowler

UNVERIFIED PROFILE

Are you Tryfonia Mainou-Fowler?   Register this Author

Register author
Tryfonia Mainou-Fowler

Tryfonia Mainou-Fowler

Publications by authors named "Tryfonia Mainou-Fowler"

Are you Tryfonia Mainou-Fowler?   Register this Author

19Publications

410Reads

21Profile Views

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Nat Commun 2017 02 6;8:14175. Epub 2017 Feb 6.

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms14175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303820PMC
February 2017

Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.

Histopathology 2013 Dec 1;63(6):788-801. Epub 2013 Oct 1.

Academic Haematology, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.12223
Publisher Site
http://dx.doi.org/10.1111/his.12223DOI Listing
December 2013

MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies.

J Clin Pathol 2013 Mar 21;66(3):249-52. Epub 2012 Nov 21.

Academic Haematology, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2012-201021DOI Listing
March 2013

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study.

Blood 2012 Jun 10;119(25):6005-15. Epub 2012 May 10.

Academic Haematology, Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-12-396556DOI Listing
June 2012

Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia.

Epigenetics 2011 Mar 1;6(3):300-6. Epub 2011 Mar 1.

Crucible Laboratory, Institute for Ageing and Health, Newcastle University, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092678PMC
http://dx.doi.org/10.4161/epi.6.3.14038DOI Listing
March 2011

Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.

Br J Haematol 2011 Jan 18;152(1):61-71. Epub 2010 Nov 18.

Newcastle Cancer Centre at the NorthernInstitute for Cancer Research, Medical School, Newcastle University, Newcastle upon Tyne, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2010.08425.xDOI Listing
January 2011

A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.

Int J Oncol 2010 Aug;37(2):367-76

Academic Haematology, Northern Institute for Cancer Research, Newcastle University, Newcastle, Tyne and Wear, NE2 4HH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000685DOI Listing
August 2010

Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics.

Int J Oncol 2009 Nov;35(5):961-71

Department of Academic Haematology, Northern Institute for Cancer Research, The University of Newcastle, Newcastle-upon-Tyne, NE2 4HH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000409DOI Listing
November 2009

CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.

Int J Oncol 2008 Jul;33(1):169-74

Academic Haematology, School of Clinical and Laboratory Sciences, William Leech Building, The Medical School, Framlington Place, Newcastle upon Tyne, Tyne and Wear, NE2 4HH, UK.

View Article

Download full-text PDF

Source
July 2008

A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.

Int J Oncol 2008 Jan;32(1):59-68

Department of Haematology, School of Clinical and Laboratory Sciences, William Leech Building, Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, NE2 4HH, UK.

View Article

Download full-text PDF

Source
January 2008

The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).

Leuk Lymphoma 2004 Mar;45(3):455-62

Haematological Sciences, School of Clinical and Laboratory Sciences, The Medical School, Leech Building, Farmington Place, Newcastle upon Tyne NE2 4HH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819032000141275DOI Listing
March 2004

Intracellular cytokine profiles by peripheral blood CD3+ T-cells in patients with classical Hodgkin lymphoma.

Leuk Lymphoma 2003 Aug;44(8):1325-31

University Department of Haematology, School of Clinical and Laboratory Sciences, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819031000090246DOI Listing
August 2003

Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.

Br J Haematol 2002 Sep;118(3):755-61

University Department of Haematology, School of Clinical and Laboratory Sciences, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03673.xDOI Listing
September 2002